Immunic Inc (IMUX)

Aug 12, 2025

What are the future prospects of Immunic Inc.July 2025 Intraday Action & Consistent Return Strategy Ideas - thegnnews.com

Aug 12, 2025

Aug 12, 2025

Immunic (IMUX) Q2 Loss Widens 25% - AOL.com

Aug 12, 2025

Aug 12, 2025

Momentum Screeners Rank Immunic Inc. in Top 5 TodayCapital Protection Trading Strategies Gain Interest - beatles.ru

Aug 12, 2025

Aug 12, 2025

H.C. Wainwright reiterates Buy rating on Immunic stock, citing positive MS data - Investing.com

Aug 12, 2025

Aug 12, 2025

H.C. Wainwright reiterates Buy rating on Immunic stock, citing positive MS data By Investing.com - Investing.com South Africa

Aug 12, 2025

Aug 12, 2025

Immunic, Inc. Advances Multiple Sclerosis Drug Trials - TipRanks

Aug 12, 2025

Aug 11, 2025

Immunic, Inc. shares rise 3.21% premarket after Novartis' positive Phase III trial results for ianalumab in Sjögren's disease. - AInvest

Aug 11, 2025

Aug 10, 2025

William Blair Maintains Immunic(IMUX.US) With Buy Rating - 富途牛牛

Aug 10, 2025

Aug 10, 2025

Is Immunic Inc. stock a value trapInvestment Timing Signals - mustnews.co.kr

Aug 10, 2025

Aug 10, 2025

Technical signs of recovery in Immunic Inc.Free Risk-Adjusted Picks With Exit Strategy - Newser

Aug 10, 2025

Aug 09, 2025

Will Immunic Inc. price bounce be sustainableFree Smart Trade Plans With Risk Protection - Newser

Aug 09, 2025

Aug 09, 2025

Intraday pattern recognizer results for Immunic Inc.Free Early Entry Tips With Low Risk Zone - Newser

Aug 09, 2025

Aug 09, 2025

Immunic reports promising Phase 2 data for lead drug candidate in progressive MSICYMI - Proactive financial news

Aug 09, 2025

Aug 09, 2025

Is a relief rally coming for Immunic Inc. holdersConservative Investment Setup and Risk Analysis - Newser

Aug 09, 2025

Aug 08, 2025

Immunic: Q2 Earnings Snapshot - Connecticut Post

Aug 08, 2025

Aug 07, 2025

Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update - The Malaysian Reserve

Aug 07, 2025

Aug 07, 2025

Small cap wrap: Immunic, Nextech3D.ai, EDM Resources, Alvopetro… - Proactive Investors

Aug 07, 2025

Aug 07, 2025

Immunic Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025

Aug 07, 2025

Immunic CEO on strong Q2 progress with vidofludimus calcium trials for MS - Proactive financial news

Aug 07, 2025

Aug 07, 2025

Immunic CEO Discusses Strong Q2 Progress in Vidofludimus Calcium Trials for MS Treatment - AInvest

Aug 07, 2025

Aug 07, 2025

Immunic advances MS drug program with Phase 3 trials fully enrolled - Proactive financial news

Aug 07, 2025

Aug 07, 2025

Immunic Advances Phase 3 Trials and Financial Health - TipRanks

Aug 07, 2025

Aug 07, 2025

Immunic Q2 net loss widens, flags potential cash raise - AInvest

Aug 07, 2025

Aug 07, 2025

Biotech Immunic Q2 net loss widens, flags need to raise cash - MarketScreener

Aug 07, 2025

Aug 07, 2025

Immunic, Inc.: A High-Potential Biotech Play in the MS and GI Therapeutics Space - AInvest

Aug 07, 2025

Aug 07, 2025

EQS-News: Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Ariva

Aug 07, 2025

Aug 07, 2025

Immunic (IMUX) to Release Quarterly Earnings on Thursday - Defense World

Aug 07, 2025

Aug 06, 2025

Immunic, Inc. shares fall 1.43% after-hours as ImmunoPrecise Antibodies Ltd. reports earnings miss and auditor raises 'going concern' doubt. - AInvest

Aug 06, 2025

Aug 04, 2025

Immunic, Inc. shares fall 2.36% premarket after Sonnet BioTherapeutics' clinical trial data shows potential for SON-1010 in ovarian cancer. - AInvest

Aug 04, 2025

Aug 04, 2025

Immunic Inc. Stock Analysis and ForecastBreakout profit opportunities - Jammu Links News

Aug 04, 2025

Aug 04, 2025

When is Immunic Inc. stock expected to show significant growthMarket-crushing stock picks - Jammu Links News

Aug 04, 2025

Aug 03, 2025

How does Immunic Inc. compare to its industry peersMaximize gains with proven stock analysis - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the dividend policy of Immunic Inc. stockMaximize returns with strategic portfolio planning - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Immunic Inc. stock in 2025Invest confidently with real-time data analysis - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the risk reward ratio of investing in Immunic Inc. stockSuperior profit margins - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for Immunic Inc. in the next 12 monthsTrack high-yield stocks before they peak - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying Immunic Inc. stockUnstoppable investment returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What drives Immunic Inc. stock priceGain access to exclusive stock analysis - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is it the right time to buy Immunic Inc. stockProven strategies for superior portfolio growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Immunic Inc. a growth stock or a value stockBuild wealth faster with consistent investment plans - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Immunic, Inc. (NASDAQ:IMUX) Receives $7.50 Consensus Target Price from Brokerages - Defense World

Aug 03, 2025

Aug 02, 2025

Published on: 2025-08-03 05:26:52 - Jammu Links News

Aug 02, 2025

Aug 02, 2025

How volatile is Immunic Inc. stock compared to the marketTurbocharged investment results - Jammu Links News

Aug 02, 2025

Aug 02, 2025

How Immunic Inc. stock performs during market volatilityAccurate Forecast System with AI Support - Newser

Aug 02, 2025

Aug 01, 2025

Immunic, Inc. shares rise 6.38% premarket after Trump pressures 17 pharma CEOs to cut US drug prices. - AInvest

Aug 01, 2025

Jul 31, 2025

Why is Immunic Inc. stock attracting strong analyst attentionBreakout Stocks Opportunities That Work - Jammu Links News

Jul 31, 2025